These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24617554)

  • 21. Imaging of contrast medium extravasation in anticoagulation-associated intracerebral hemorrhage with dual-energy computed tomography.
    Won SY; Schlunk F; Dinkel J; Karatas H; Leung W; Hayakawa K; Lauer A; Steinmetz H; Lo EH; Foerch C; Gupta R
    Stroke; 2013 Oct; 44(10):2883-90. PubMed ID: 23920016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of dabigatran-induced bleeding with a prothrombin complex concentrate and fresh frozen plasma.
    Dumkow LE; Voss JR; Peters M; Jennings DL
    Am J Health Syst Pharm; 2012 Oct; 69(19):1646-50. PubMed ID: 22997117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The trouble with dabigatran.
    Charlton B; Redberg R
    BMJ; 2014 Jul; 349():g4681. PubMed ID: 25055830
    [No Abstract]   [Full Text] [Related]  

  • 24. Hemodialysis for the treatment of pulmonary hemorrhage from dabigatran overdose.
    Chen BC; Sheth NR; Dadzie KA; Smith SW; Nelson LS; Hoffman RS; Winchester JF
    Am J Kidney Dis; 2013 Sep; 62(3):591-4. PubMed ID: 23597859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dabigatran therapy: minor trauma injuries are no longer minor.
    Joseph B; Ditillo M; Pandit V; Aziz H; Sadoun M; Hays D; Davis K; Friese R; Rhee P
    Am Surg; 2014 Apr; 80(4):E116-8. PubMed ID: 24887656
    [No Abstract]   [Full Text] [Related]  

  • 26. Concerns over data in key dabigatran trial.
    Cohen D
    BMJ; 2014 Jul; 349():g4747. PubMed ID: 25055831
    [No Abstract]   [Full Text] [Related]  

  • 27. Removal of dabigatran by hemodialysis.
    Chang DN; Dager WE; Chin AI
    Am J Kidney Dis; 2013 Mar; 61(3):487-9. PubMed ID: 23219111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Patient with acute renal injury presenting dabigatran overdose: Hemodialysis for surgery].
    Bachellerie B; Ruiz S; Conil JM; Crognier L; Seguin T; Georges B; Fourcade O
    Ann Fr Anesth Reanim; 2014 Jan; 33(1):44-6. PubMed ID: 24378048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dabigatran and postmarketing reports of bleeding.
    Southworth MR; Reichman ME; Unger EF
    N Engl J Med; 2013 Apr; 368(14):1272-4. PubMed ID: 23484796
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of FEIBA® in the correction of coagulation abnormalities induced by dabigatran.
    Khoo TL; Weatherburn C; Kershaw G; Reddel CJ; Curnow J; Dunkley S
    Int J Lab Hematol; 2013 Apr; 35(2):222-4. PubMed ID: 23020832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin.
    Berger R; Salhanick SD; Chase M; Ganetsky M
    Ann Emerg Med; 2013 Apr; 61(4):475-9. PubMed ID: 23522810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran.
    Bouchard J; Ghannoum M; Bernier-Jean A; Williamson D; Kershaw G; Weatherburn C; Eris JM; Tran H; Patel JP; Roberts DM
    Clin Toxicol (Phila); 2015 Mar; 53(3):156-63. PubMed ID: 25661675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombolysis treatment for acute ischaemic stroke in a patient on treatment with dabigatran.
    Matute MC; Guillán M; García-Caldentey J; Buisan J; Aparicio M; Masjuan J; Alonso de Leciñana M
    Thromb Haemost; 2011 Jul; 106(1):178-9. PubMed ID: 21505718
    [No Abstract]   [Full Text] [Related]  

  • 34. Dabigatran: life-threatening bleeding.
    Prescrire Int; 2013 Feb; 22(135):41-3. PubMed ID: 23444501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fatality in a patient treated with dabigatran.
    Schattner A; Kozak N; Friedman J
    Am J Emerg Med; 2013 Feb; 31(2):443.e1-2. PubMed ID: 22867831
    [No Abstract]   [Full Text] [Related]  

  • 36. Bleeding events and activated partial thromboplastin time with dabigatran in clinical practice.
    Kawabata M; Yokoyama Y; Sasano T; Hachiya H; Tanaka Y; Yagishita A; Sugiyama K; Nakamura T; Suzuki M; Isobe M; Hirao K
    J Cardiol; 2013 Aug; 62(2):121-6. PubMed ID: 23680005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ischemic stroke and intestinal bleeding under dabigatran in metabolic myopathy.
    Finsterer J; Stöllberger C; Paul G; Bastovansky A
    Cardiovasc Ther; 2013 Dec; 31(6):e111-4. PubMed ID: 24279385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Traumatic intracranial hemorrhage in patients taking dabigatran: report of 3 cases and review of the literature.
    Wassef SN; Abel TJ; Grossbach A; Viljoen SV; Jackson AW; Howard MA; Greenlee JD
    Neurosurgery; 2013 Aug; 73(2):E368-73; discussion E373-4. PubMed ID: 23670031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran.
    Alikhan R; Rayment R; Keeling D; Baglin T; Benson G; Green L; Marshall S; Patel R; Pavord S; Rose P; Tait C
    Emerg Med J; 2014 Feb; 31(2):163-8. PubMed ID: 23435652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ischemic stroke in an obese patient receiving dabigatran.
    Breuer L; Ringwald J; Schwab S; Köhrmann M
    N Engl J Med; 2013 Jun; 368(25):2440-2. PubMed ID: 23782198
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.